Novozymes has signed a definitive agreement to acquire TJ Technologies Inc. based in Watertown, South Dakota. The move was made in an effort to continue to build Novozymes’ business in the BioAgriculture sector. TJ Technologies specializes in bioyield enhancement.

“With this acquisition we continue to build our business within sustainable bioagriculture. TJ Technologies Inc. is a frontrunner in bioyield enhancers, and this acquisition will further underpin Novozymes’ position, while strengthening commercial access,” said Thomas Videbæk, Executive Vice President of Novozymes and head of Business Development. “Combining our existing products and leading global name with TJ Technologies’ strong and proven portfolio, brands and regional market coverage will strengthen the joint company’s commercial position in important crop markets.”

TJ Technologies was founded in 1978 and develops and markets proprietary microbial and micronutrient products for agriculture. It is a significant participant in the U.S. market for bioyield enhancement products, with a strong position in seed treatment of corn as well as other important crops.

“With its proven portfolio of products and new pipeline opportunities, TJ Technologies’ talented employees will add solid experience and knowhow to Novozymes, which can leverage its leading position to bring the existing products to market, and further develop new innovation and growth opportunities for the bioagriculture market,” added Videbæk.